Trial Profile
Japan Prevention Trial of Diabetes by Pitavastatin in Patients With Impaired Glucose Tolerance (J-PREDICT).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Pitavastatin (Primary)
- Indications Glucose intolerance; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms J-PREDICT
- 09 Jun 2015 Results of a subanalysis in lean patients with impaired glucose tolerance presented at the 75th Annual Scientific Sessions of the American Diabetes Association.
- 19 Sep 2014 Post-hoc analysis results were presented at the 50th Annual Meeting of the European Association for the Study of Diabetes.
- 25 Sep 2013 Results presented at the 49th Annual Meeting of the European Association for the Study of Diabetes.